Effects of phase constitution on magnetic susceptibility and mechanical properties of Zr-rich Zr-Mo alloys

Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Acta biomaterialia (Impact Factor: 6.03). 07/2011; 7(12):4259-66. DOI: 10.1016/j.actbio.2011.07.005
Source: PubMed

ABSTRACT The effects of the microstructures and phases of Zr-rich Mo alloys on their magnetic susceptibilities and mechanical properties were investigated in order to develop a Zr alloy with low magnetic susceptibility for use in magnetic resonance imaging (MRI). The magnetic susceptibility was measured with a magnetic susceptibility balance, while mechanical properties were evaluated by a tensile test. The microstructure was evaluated with an X-ray diffractometer, an optical microscope, and a transmission electron microscope. Evaluation of the microstructures revealed that the α' phase was the dominant form at less than 2% Mo content in the as-cast alloy. The ω phase was formed in as-cast Zr-3Mo but disappeared with aging at 973 K. Magnetic susceptibility was reflected in the phase constitution: the susceptibility showed a local minimum at Zr-(0.5-1)Mo with mostly α' phase and a minimum at Zr-3Mo with mostly β and ω phases. The magnetic susceptibility of as-cast Zr-3Mo increased at 973 K due to disappearance of the ω phase. However, the susceptibility was still as low as that of as-cast Zr-1Mo. The ultimate tensile strength of α'-based Zr-Mo alloys was tailored from 674 to 970 MPa, and the corresponding elongation varied from 11.1% to 2.9%. Because Zr-Mo alloys containing ω phase were found, through tensile tests, to be brittle this phase should be avoided, irrespective of the low magnetic susceptibility, in order to maintain mechanical reliability. Elongation of the Zr-3Mo alloy was dramatically improved when the phase constitution was changed to α and β phases by aging at 973 K for 86.4 ks. The magnetic susceptibilities of the α'-based Zr-Mo alloys are one-third those of Ti-6Al-4V and Ti-6Al-7Nb, and thus these Zr alloys are useful for medical devices under MRI.

8 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Great deal of research is still going on in the field of orthopedic and craniofacial implant development to resolve various issues being faced by the industry today. Despite several disadvantages of the metallic implants, they continue to be used, primarily because of their superior mechanical properties. In order to minimize the harmful effects of the metallic implants and its by-products, several modifications are being made to these materials, for instance nickel-free stainless steel, cobalt-chromium and titanium alloys are being introduced to eliminate the toxic effects of nickel being released from the alloys, introduce metallic implants with lower modulus, reduce the cost of these alloys by replacing rare elements with less expensive elements etc. New alloys like tantalum, niobium, zirconium, and magnesium are receiving attention given their satisfying mechanical and biological properties. Non-oxide ceramics like silicon nitride and silicon carbide are being currently developed as a promising implant material possessing a combination of properties such as good wear and corrosion resistance, increased ductility, good fracture and creep resistance, and relatively high hardness in comparison to alumina. Polymer/magnesium composites are being developed to improve mechanical properties as well as retain polymer's property of degradation. Recent advances in orthobiologics are proving interesting as well. This paper thus deals with the latest improvements being made to the existing implant materials and includes new materials being introduced in the field of biomaterials. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
    Journal of Biomedical Materials Research Part A 06/2012; 101(11):NA. DOI:10.1002/jbm.a.34605 · 3.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: New low modulus β-type titanium alloys for biomedical applications are still currently being developed. Strong and enduring β-type titanium alloy with a low Young's modulus are being investigated. A low modulus has been proved to be effective in inhibiting bone atrophy, leading to good bone remodeling in a bone fracture model in the rabbit tibia. Very recently β-type titanium alloys with a self-tunable modulus have been proposed for the construction of removable implants. Nickel-free low modulus β-type titanium alloys showing shape memory and super elastic behavior are also currently being developed. Nickel-free stainless steel and cobalt-chromium alloys for biomedical applications are receiving attention as well. Newly developed zirconium-based alloys for biomedical applications are proving very interesting. Magnesium-based or iron-based biodegradable biomaterials are under development. Further, tantalum, and niobium and its alloys are being investigated for biomedical applications. The development of new metallic alloys for biomedical applications is described in this paper.
    Acta biomaterialia 07/2012; 8(11):3888-903. DOI:10.1016/j.actbio.2012.06.037 · 6.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, the microstructure, mechanical properties, corrosion behaviors, and in vitro biocompatibility of Zr-Mo alloys as a function of Mo content after solution treatment were systemically investigated to assess their potential use in biomedical application. The experimental results indicated that Zr-1Mo alloy mainly consisted of an acicular structure of α' phase, while ω phase formed in Zr-3Mo alloy. In Zr-5Mo alloy, retained β phase and a small amount of precipitated α phase were observed. Only the retained β phase was obtained in Zr-10Mo alloy. Zr-1Mo alloy exhibited the greatest hardness, bending strength, and modulus among all experimental Zr-Mo alloys, while β phase Zr-10Mo alloy had a low modulus. The results of electrochemical corrosion indicated that adding Mo into Zr improved its corrosion resistance which resulted in increasing the thermodynamic stability and passivity of zirconium. The cytotoxicity test suggested that the extracts of the studied Zr-Mo alloys produced no significant deleterious effect to fibroblast cells (L-929) and osteoblast cells (MG 63), indicating an excellent in vitro biocompatibility. Based on these facts, certain Zr-Mo alloys potentially suitable for different biomedical applications were proposed. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
    Journal of Biomedical Materials Research Part B Applied Biomaterials 02/2013; 101B(2). DOI:10.1002/jbm.b.32833 · 2.76 Impact Factor
Show more